Sunshine Biopharma Stock Price History

SBFM Stock  USD 1.56  0.04  2.50%   
Below is the normalized historical share price chart for Sunshine Biopharma extending back to October 30, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sunshine Biopharma stands at 1.56, as last reported on the 20th of July, with the highest price reaching 1.60 and the lowest price hitting 1.54 during the day.
IPO Date
30th of October 2009
200 Day MA
2.2424
50 Day MA
1.4737
Beta
0.959
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Sunshine Stock, it is important to understand the factors that can impact its price. Sunshine Biopharma appears to be dangerous, given 3 months investment horizon. Sunshine Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0875, which indicates the firm had a 0.0875 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Sunshine Biopharma, which you can use to evaluate the volatility of the company. Please review Sunshine Biopharma's Risk Adjusted Performance of 0.0825, coefficient of variation of 1253.67, and Semi Deviation of 3.77 to confirm if our risk estimates are consistent with your expectations.
At this time, Sunshine Biopharma's Total Stockholder Equity is very stable compared to the past year. As of the 20th of July 2025, Common Stock Shares Outstanding is likely to grow to about 736.8 K, while Capital Stock is likely to drop about 14.8 K. . As of the 20th of July 2025, Price Earnings To Growth Ratio is likely to grow to 0, while Price To Sales Ratio is likely to drop 0.06. Sunshine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0875

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsSBFM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.63
  actual daily
41
59% of assets are more volatile

Expected Return

 0.41
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
6
94% of assets perform better
Based on monthly moving average Sunshine Biopharma is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sunshine Biopharma by adding it to a well-diversified portfolio.
Price Book
0.3132
Enterprise Value Ebitda
(7.73)
Price Sales
0.1961
Shares Float
4.6 M
Wall Street Target Price
7

Sunshine Biopharma Stock Price History Chart

There are several ways to analyze Sunshine Stock price data. The simplest method is using a basic Sunshine candlestick price chart, which shows Sunshine Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJune 11, 20251.7
Lowest PriceMay 8, 20251.23

Sunshine Biopharma July 20, 2025 Stock Price Synopsis

Various analyses of Sunshine Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sunshine Stock. It can be used to describe the percentage change in the price of Sunshine Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sunshine Stock.
Sunshine Biopharma Price Daily Balance Of Power(0.67)
Sunshine Biopharma Price Rate Of Daily Change 0.98 
Sunshine Biopharma Price Action Indicator(0.03)

Sunshine Biopharma July 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Sunshine Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Sunshine Biopharma intraday prices and daily technical indicators to check the level of noise trading in Sunshine Stock and then apply it to test your longer-term investment strategies against Sunshine.

Sunshine Stock Price History Data

The price series of Sunshine Biopharma for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 0.48 with a coefficient of variation of 7.61. The price distribution for the period has arithmetic mean of 1.45. The median price for the last 90 days is 1.46. The company completed stock split (1:20) on 8th of August 2024. Sunshine Biopharma had dividends distributed to its stock-holders on 2020-04-06.
OpenHighLowCloseVolume
07/20/2025
 1.60  1.60  1.54  1.56 
07/18/2025
 1.60  1.60  1.54  1.56  75,385 
07/17/2025
 1.56  1.60  1.53  1.60  104,726 
07/16/2025
 1.53  1.53  1.47  1.52  45,406 
07/15/2025
 1.45  1.56  1.42  1.51  150,507 
07/14/2025
 1.54  1.54  1.45  1.49  172,541 
07/11/2025
 1.59  1.59  1.50  1.54  79,999 
07/10/2025
 1.56  1.61  1.56  1.60  74,805 
07/09/2025
 1.48  1.61  1.48  1.56  115,513 
07/08/2025
 1.46  1.53  1.43  1.52  78,434 
07/07/2025
 1.56  1.56  1.44  1.47  159,358 
07/03/2025
 1.65  1.65  1.53  1.55  292,844 
07/02/2025 1.48  1.75  1.42  1.65  2,058,437 
07/01/2025
 1.44  1.49  1.43  1.45  25,401 
06/30/2025
 1.44  1.46  1.42  1.44  42,192 
06/27/2025
 1.45  1.54  1.39  1.46  76,511 
06/26/2025
 1.41  1.47  1.39  1.47  44,614 
06/25/2025
 1.49  1.58  1.40  1.41  139,365 
06/24/2025
 1.43  1.49  1.43  1.49  26,635 
06/23/2025
 1.44  1.49  1.41  1.43  27,990 
06/20/2025
 1.44  1.50  1.44  1.44  41,437 
06/18/2025
 1.48  1.51  1.41  1.48  20,703 
06/17/2025
 1.57  1.63  1.44  1.47  146,072 
06/16/2025
 1.55  1.70  1.51  1.61  103,295 
06/13/2025
 1.57  1.59  1.53  1.55  69,483 
06/12/2025
 1.75  1.75  1.58  1.59  91,333 
06/11/2025 1.70  1.81  1.66  1.70  133,920 
06/10/2025
 1.58  1.72  1.58  1.69  165,879 
06/09/2025
 1.51  1.59  1.49  1.57  59,022 
06/06/2025
 1.45  1.53  1.45  1.51  55,339 
06/05/2025
 1.46  1.55  1.46  1.48  54,651 
06/04/2025
 1.54  1.56  1.50  1.51  101,859 
06/03/2025
 1.46  1.55  1.43  1.55  131,141 
06/02/2025
 1.41  1.50  1.38  1.42  166,904 
05/30/2025
 1.42  1.44  1.37  1.43  44,167 
05/29/2025
 1.45  1.47  1.43  1.44  42,556 
05/28/2025
 1.41  1.47  1.39  1.44  46,331 
05/27/2025
 1.48  1.48  1.40  1.43  65,215 
05/23/2025
 1.37  1.44  1.37  1.44  61,561 
05/22/2025
 1.41  1.42  1.37  1.40  78,295 
05/21/2025
 1.48  1.49  1.39  1.42  107,654 
05/20/2025
 1.46  1.50  1.45  1.50  88,535 
05/19/2025
 1.45  1.50  1.42  1.49  91,845 
05/16/2025
 1.32  1.54  1.32  1.50  370,887 
05/15/2025 1.39  1.39  1.31  1.32  116,781 
05/14/2025
 1.38  1.41  1.31  1.39  136,205 
05/13/2025
 1.32  1.37  1.32  1.36  88,679 
05/12/2025
 1.28  1.36  1.28  1.35  143,331 
05/09/2025
 1.21  1.28  1.21  1.25  98,988 
05/08/2025
 1.27  1.31  1.21  1.23  208,942 
05/07/2025
 1.31  1.31  1.24  1.27  95,352 
05/06/2025 1.33  1.33  1.27  1.31  163,251 
05/05/2025
 1.34  1.39  1.24  1.27  143,411 
05/02/2025
 1.41  1.45  1.32  1.37  184,995 
05/01/2025
 1.34  1.44  1.34  1.41  75,353 
04/30/2025
 1.39  1.40  1.31  1.35  109,797 
04/29/2025
 1.41  1.44  1.36  1.39  108,169 
04/28/2025
 1.48  1.51  1.37  1.44  241,193 
04/25/2025
 1.51  1.57  1.45  1.51  165,964 
04/24/2025
 1.60  1.60  1.46  1.55  268,705 
04/23/2025
 1.48  1.60  1.41  1.47  657,599 

About Sunshine Biopharma Stock history

Sunshine Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sunshine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sunshine Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sunshine Biopharma stock prices may prove useful in developing a viable investing in Sunshine Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding701.7 K736.8 K
Net Loss-24.1 M-22.9 M

Sunshine Biopharma Stock Technical Analysis

Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sunshine Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sunshine Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Sunshine Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sunshine Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sunshine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sunshine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Sunshine Biopharma is a strong investment it is important to analyze Sunshine Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sunshine Biopharma's future performance. For an informed investment choice regarding Sunshine Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.76)
Revenue Per Share
29.768
Quarterly Revenue Growth
0.18
Return On Assets
(0.12)
Return On Equity
(0.21)
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.